glp-1 diarrhea treatment America's Poison Centers GLP-1 Medications Infographic | Medidex

The safe peptides for women guide addresses age-specific safety considerations

Updated April 13, 2023

PKA inhibiting delayed rectifying K + channels lengthen action potentials

The half-lives of dulaglutide (~90 h) and semaglutide (Ozempic) (~160 h) are substantially longer than some other formulations of GLP-1RAs (24)

Clinical trials show average weight loss of 1522% of body weight over 68 weeks with GLP-1 therapy, though individual results vary based on genetics, lifestyle, and medication response

( 10.1016/j.molmet.2020.101090) [DOI] [PMC free article] [PubMed] [Google Scholar] Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJ, et al